ORIGINAL RESEARCH article
Front. Aging Neurosci., 11 August 2022
Sec. Alzheimer's Disease and Related Dementias
Volume 14 - 2022 | https://doi.org/10.3389/fnagi.2022.960246
RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
- DA
Deepshi Arora 1,2
- SB
Shailendra Bhatt 3
- MK
Manish Kumar 1*
- RV
Ravinder Verma 3
- YT
Yugam Taneja 4
- NK
Nikita Kaushal 1
- AT
Abhishek Tiwari 5
- VT
Varsha Tiwari 5
- AA
Athanasios Alexiou 6,7
- SA
Sarah Albogami 8
- SS
Saqer S. Alotaibi 8
- VM
Vineet Mittal 9
- RK
Rajeev K. Singla 10,11
- DK
Deepak Kaushik 9*
- GE
Gaber El-Saber Batiha 12*
1. M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Ambala, Haryana, India
2. Guru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India
3. Department of Pharmacy, G.D. Goenka University, Gurugram, Haryana, India
4. Zeon Lifesciences Pvt. Ltd., Paonta Sahib, Himachal Pradesh, India
5. Pharmacy Academy, IFTM University, Moradabad, UP, India
6. Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, NSW, Australia
7. AFNP Med Austria, Wien, Austria
8. College of Science, Taif University, Taif, Saudi Arabia
9. Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India
10. Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China
11. iGlobal Research and Publishing Foundation, New Delhi, India
12. Faculty of Veterinary Medicine, Department of Pharmacology and Therapeutics, Damanhour University, Damanhour, Egypt
Summary
Citation
Arora D, Bhatt S, Kumar M, Verma R, Taneja Y, Kaushal N, Tiwari A, Tiwari V, Alexiou A, Albogami S, Alotaibi SS, Mittal V, Singla RK, Kaushik D and Batiha GE-S (2022) RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics. Front. Aging Neurosci. 14:960246. doi: 10.3389/fnagi.2022.960246
Received
02 June 2022
Accepted
14 July 2022
Published
11 August 2022
Volume
14 - 2022
Edited by
Patrick R. Hof, Icahn School of Medicine at Mount Sinai, United States
Reviewed by
Ashok Iyaswamy, Hong Kong Baptist University, Hong Kong SAR, China; Simona Cavalu, University of Oradea, Romania
Updates
This article was submitted to Alzheimer's Disease and Related Dementias, a section of the journal Frontiers in Aging Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.